瑞典CellaVision
CellaVision AB 开发、营销并销售市场领先的用于血液和其他体液常规分析的图像分析系统。公司在开发用于健康和医疗护理的细胞和细胞变化的自动图像分析的软硬件领域具有核心竞争力。它开发并营销白细胞和红细胞的自动分类系统，以及分类的教学和质量保证软件。公司的合作者拥有高级图像分析、人工智能和自动显微镜学的专业技术。

公司总部位于瑞典的隆德（Lund），在美国佛罗里达，加拿大多伦多和日本的横滨都有分支机构。

CellaVision AB develops and markets products for the health care sector, enabling fast and firm blood cell analysis and quality assurance of morphology diagnosis.

The company has cutting-edge expertise within sophisticated digital image analysis, artificial intelligence and automated microscopy. For laboratories, this means increased efficiency, a simplification of the procedures and confirmed proficiency.
 

The product line includes systems for automatic blood cell differentials and software for differential proficiency testing and education. The products are sold to hospital laboratories and independent commercial laboratories. Today CellaVision is represented in Europe, the U.S. and to some extent in Asia.

Vision
To create a global de facto standard for digital microscopy analysis and thereby contribute to improved care quality and cost efficient medical care

Background
Based in Lund, Sweden, CellaVision was founded in 1994. The CellaVision concept of automated microscopy analysis comes from Christer Fåhraeus and engineers connected to Lund Institute of Technology and the Ideon Science Park. Since 2001, the company also has a U.S. subsidiary in Jupiter, Fl, USA. In January 2007, a subsidiary in Toronto, ON, Canada was established, and one year later a subsidiary in Yokohama, Japan.

Owners
CellaVision has about 700 shareholders who have provided capital in connection with new stock issues. The principal owner is H&B Capital LP. Other major shareholders are Stiftelsen Industrifonden, Metallica Förvaltnings AB, Christer Fåhraeus, Life Equity Sweden KB and SIF.